| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0026-0495(96)90024-4 |
| P698 | PubMed publication ID | 8622597 |
| P2093 | author name string | Y Shigeta | |
| A Kashiwagi | |||
| H Maegawa | |||
| N Takahara | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE | Q28236539 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells | Q34128848 | ||
| Monocyte chemoattractant protein-1 in human atheromatous plaques | Q34203056 | ||
| Structure of human monocyte chemotactic protein gene and its regulation by TPA. | Q34661435 | ||
| Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
| Role of oxidized low density lipoprotein in atherogenesis | Q40343074 | ||
| The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules | Q41520897 | ||
| Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins | Q59060592 | ||
| Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation | Q67573946 | ||
| A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1) | Q68074597 | ||
| Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody | Q72080088 | ||
| Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells | Q72797905 | ||
| P433 | issue | 5 | |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 559-564 | |
| P577 | publication date | 1996-05-01 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells | |
| P478 | volume | 45 |
| Q64057248 | An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases |
| Q37152620 | An evolving new paradigm: endothelial cells--conditional innate immune cells |
| Q41069885 | Apoptosis triggered by 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine is prevented by increased expression of CTP:phosphocholine cytidylyltransferase |
| Q33842405 | Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. |
| Q33772440 | Chemokines and atherosclerosis |
| Q43125114 | Curcumin blocks CCL2-induced adhesion, motility and invasion, in part, through down-regulation of CCL2 expression and proteolytic activity. |
| Q77379029 | Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients |
| Q32054601 | Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis |
| Q73764245 | IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells |
| Q37340646 | Identification of lysophosphatidylcholine-chlorohydrin in human atherosclerotic lesions. |
| Q34016317 | Inhibition of lipoprotein-associated phospholipase A2 ameliorates inflammation and decreases atherosclerotic plaque formation in ApoE-deficient mice |
| Q36269180 | Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke |
| Q36562248 | Lipoprotein-associated phospholipase A2: pathogenic mechanisms and clinical utility for predicting cardiovascular events |
| Q33664272 | Lp-PLA2 Inhibition-The Atherosclerosis Panacea? |
| Q34775050 | Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration |
| Q46889699 | Lysophosphatidylcholine as a ligand for immunoregulation |
| Q80079006 | Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells |
| Q43901462 | Lysophosphatidylcholine inhibits the expression of prostacyclin stimulating factor in cultured vascular smooth muscle cells |
| Q35541858 | Role of Monocytes in Atherogenesis |
| Q34470222 | The role of chemokines in human cardiovascular pathology: enhanced biological insights |
| Q34064170 | The role of protein kinase C in the development of the complications of diabetes |
| Q36974519 | Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholine |
Search more.